Why the study?
Do selective serotonin reuptake inhibitors (SSRIs) increase the risk of violent or suicidal behaviour in treated patients?
Do selective serotonin reuptake inhibitors (SSRIs) increase the risk of violent or suicidal behaviour in treated patients?
There is no convincing evidence linking SSRIs causally to violence and suicide, and they may actually reduce aggression.
Reassures on SSRI safety regarding aggression in practice; leaves open any protective effect pending prospective trials.
OBJECTIVE: To provide a clinically useful analysis of the relationship between selective serotonin reuptake inhibitors (SSRIs), in particular fluoxetine and violent or suicidal behaviour. METHOD: All published papers on Medline and other databases linking serotonin, SSRIs and aggression were reviewed. RESULTS: A small proportion of patients treated with SSRIs may become akathisic and others may show increases in anxiety in the initial phase of treatment, but no increased susceptibility to aggression or suicidality can be connected with fluoxetine or any other SSRI. In fact SSRI treatment may reduce aggression, probably due to positive effects on the serotonergic dysfunction that is implicated in aggressive behaviour directed towards oneself or others. CONCLUSION: In the absence of convincing evidence to link SSRIs causally to violence and suicide, the recent lay media reports are potentially dangerous, unnecessarily increasing the concerns of depressed patients who are prescribed antidepressants.
No takes yet. Share an insight, caveat, or question.
Walsh et al. (2001) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: